Literature DB >> 11509365

Comprehensive kinetic analysis of influenza hemagglutinin-mediated membrane fusion: role of sialate binding.

A Mittal1, J Bentz.   

Abstract

The data of Danieli et al. (J. Cell Biol. 133:559-569, 1996) and Blumenthal et al. (J. Cell Biol. 135:63-71, 1996) for fusion between hemagglutinin (HA)-expressing cells and fluorescently labeled erythrocytes has been analyzed using a recently published comprehensive mass action kinetic model for HA-mediated fusion. This model includes the measurable steps in the fusion process, i.e., first pore formation, lipid mixing, and content mixing of aqueous fluorescent markers. It contains two core parameters of the fusion site architecture. The first is the minimum number of aggregated HAs needed to sustain subsequent fusion intermediates. The second is the minimal number of those HAs within the fusogenic aggregate that must undergo a slow "essential" conformational change needed to initiate bilayer destabilization. Because the kinetic model has several parameters, each data set was exhaustively fitted to obtain all best fits. Although each of the data sets required particular parameter ranges for best fits, a consensus subset of these parameter ranges could fit all of the data. Thus, this comprehensive model subsumes the available mass action kinetic data for the fusion of HA-expressing cells with erythrocytes, despite the differences in assays and experimental design, which necessitated transforming fluorescence dequenching intensities to equivalent cumulative waiting time distributions. We find that HAs bound to sialates on glycophorin can participate in fusion as members of the fusogenic aggregate, but they cannot undergo the essential conformational change that initiates bilayer destabilization, thus solving a long-standing debate. Also, the similarity in rate constants for lipid mixing and content mixing found here for HA-mediated fusion and by Lee and Lentz (Proc. Natl. Acad. Sci. U.S.A. 95:9274-9279, 1998) for PEG-induced fusion of phosphatidylcholine liposomes supports the idea that subsequent to stable fusion pore formation, the evolution of fusion intermediates is determined more by the lipids than by the proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509365      PMCID: PMC1301630          DOI: 10.1016/S0006-3495(01)75806-7

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  48 in total

Review 1.  Control of biological activities of influenza virus hemagglutinin by its carbohydrate moiety.

Authors:  M Ohuchi; R Ohuchi; A Matsumoto
Journal:  Microbiol Immunol       Date:  1999       Impact factor: 1.955

2.  Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.

Authors:  S Günther-Ausborn; P Schoen; I Bartoldus; J Wilschut; T Stegmann
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.

Authors:  G B Melikyan; R M Markosyan; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

Review 4.  Protein machines and lipid assemblies: current views of cell membrane fusion.

Authors:  B R Lentz; V Malinin; M E Haque; K Evans
Journal:  Curr Opin Struct Biol       Date:  2000-10       Impact factor: 6.809

5.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

6.  The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.

Authors:  R M Markosyan; F S Cohen; G B Melikyan
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

Review 7.  Deployment of membrane fusion protein domains during fusion.

Authors:  J Bentz; A Mittal
Journal:  Cell Biol Int       Date:  2000       Impact factor: 3.612

8.  Delay of influenza hemagglutinin refolding into a fusion-competent conformation by receptor binding: a hypothesis.

Authors:  E Leikina; I Markovic; L V Chernomordik; M M Kozlov
Journal:  Biophys J       Date:  2000-09       Impact factor: 4.033

9.  Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy.

Authors:  C Böttcher; K Ludwig; A Herrmann; M van Heel; H Stark
Journal:  FEBS Lett       Date:  1999-12-17       Impact factor: 4.124

10.  Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events.

Authors:  R Blumenthal; D P Sarkar; S Durell; D E Howard; S J Morris
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

View more
  14 in total

1.  Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin.

Authors:  Eugenia Leikina; Corinne Ramos; Ingrid Markovic; Joshua Zimmerberg; Leonid V Chernomordik
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

2.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Thuy Thanh Tran; Aditya Mittal; Tanya Aldinger; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

3.  Functional motions of influenza virus hemagglutinin: a structure-based analytical approach.

Authors:  Basak Isin; Pemra Doruker; Ivet Bahar
Journal:  Biophys J       Date:  2002-02       Impact factor: 4.033

4.  Measuring pKa of activation and pKi of inactivation for influenza hemagglutinin from kinetics of membrane fusion of virions and of HA expressing cells.

Authors:  Aditya Mittal; Tong Shangguan; Joe Bentz
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

5.  Relating influenza virus membrane fusion kinetics to stoichiometry of neutralizing antibodies at the single-particle level.

Authors:  Jason J Otterstrom; Boerries Brandenburg; Martin H Koldijk; Jarek Juraszek; Chan Tang; Samaneh Mashaghi; Ted Kwaks; Jaap Goudsmit; Ronald Vogels; Robert H E Friesen; Antoine M van Oijen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

6.  Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines.

Authors:  I Markovic; E Leikina; M Zhukovsky; J Zimmerberg; L V Chernomordik
Journal:  J Cell Biol       Date:  2001-11-26       Impact factor: 10.539

7.  Molecular dynamics simulation of the evolution of hydrophobic defects in one monolayer of a phosphatidylcholine bilayer: relevance for membrane fusion mechanisms.

Authors:  D Peter Tieleman; Joe Bentz
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

8.  An allosteric rheostat in HIV-1 gp120 reduces CCR5 stoichiometry required for membrane fusion and overcomes diverse entry limitations.

Authors:  Emily J Platt; James P Durnin; Ujwal Shinde; David Kabat
Journal:  J Mol Biol       Date:  2007-09-12       Impact factor: 5.469

9.  Oligomeric beta-structure of the membrane-bound HIV-1 fusion peptide formed from soluble monomers.

Authors:  Jun Yang; Mary Prorok; Francis J Castellino; David P Weliky
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

10.  Kinetically differentiating influenza hemagglutinin fusion and hemifusion machines.

Authors:  Aditya Mittal; Eugenia Leikina; Leonid V Chernomordik; Joe Bentz
Journal:  Biophys J       Date:  2003-09       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.